Outcome of the Boad Meeting held today i.e. September 3, 2025 to recommend payment of Final Dividend for the Fianancial Year ended 31st March, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.3 pts less than Nifty Microcap 250 and 1.8 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
ZR2 Bioenergy Ltd's Board, at its meeting on September 3, 2025, recommended a final dividend of Rs. 0.10 per equity share (10% on the Rs. 1 face value) for FY ended March 31, 2025, subject to shareholder approval at the upcoming AGM. The record date for the dividend has been set as September 9, 2025. The Board also approved the appointment of M/s Ritika Agarwal & Associates as Secretarial Auditor for a five-year term (FY 2025-26 to FY 2029-30) and recommended the re-appointment of Mr. Nilesh Jayant Jain as director, who retires by rotation. Additionally, the Board approved shifting the registered office from Gujarat to Maharashtra, reclassifying the authorised share capital (converting all of it into 10 crore equity shares of Rs. 1 each), and formulating an Employee Stock Option Plan named 'ZR2 Bioenergy ESOP 2025'.
The final dividend of Rs. 0.10 per share is a modest payout, and its yield impact on the stock depends on the current market price. The proposed capital restructuring, registered office shift, and new ESOP plan suggest the company is positioning for future fundraising or expansion, but all key items require shareholder approval at the 86th AGM before they take effect.